LY310762 25 mg | 98.00%
TargetMol
LY310762
Search Results
LY310762 5 mg | 98.00%
TargetMol
LY310762
(E)-Daporinad 100 mg | Purity Not Available
TargetMol
Daporinad is a small molecule inhibitor of nicotinamide phosphoribosyltransferase (NMPRTase), with potential antineoplastic and antiangiogenic activities.
More Information Supplier Page(E)-Daporinad
Org 27569 100 mg | 98.00%
TargetMol
Org 27569, an allosteric modulator of cannabinoid CB1 receptor, can induce a CB1 receptor state that is characterized by decreased inverse agonist affinity and enhanced agonist affinity.
More Information Supplier PageOrg 27569
Ro3280 25 mg | Purity Not Available
TargetMol
Ro3280 (Ro5203280) is an effective, specific inhibitor of PLK1(IC50=3, Kd=0.09 nM).
More Information Supplier PageRo3280
Ro3280 1 mg | Purity Not Available
TargetMol
Ro3280 (Ro5203280) is an effective, specific inhibitor of PLK1(IC50=3, Kd=0.09 nM).
More Information Supplier PageRo3280
GSK 650394 100 mg | 98.93%
TargetMol
GSK 650394 is a serum- and glucocorticoid-regulated kinase-1 inhibitor.
More Information Supplier PageGSK 650394
GSK 650394 2 mg | 98.93%
TargetMol
GSK 650394 is a serum- and glucocorticoid-regulated kinase-1 inhibitor.
More Information Supplier PageGSK 650394
GSK2656157 2 mg | 99.89%
TargetMol
GSK2656157 is a highly specific and ATP-competitive PERK inhibitor (IC50: 0.9 nM) in a cell-free assay. The selectivty is 500-fold higher against a panel of 300 kinases.
More Information Supplier PageGSK2656157
GSK2656157 25 mg | 99.89%
TargetMol
GSK2656157 is a highly specific and ATP-competitive PERK inhibitor (IC50: 0.9 nM) in a cell-free assay. The selectivty is 500-fold higher against a panel of 300 kinases.
More Information Supplier PageGSK2656157